Navigation Links
Immucor Responding to FDA Warning Letter
Date:5/13/2008

NORCROSS, Ga., May 13 /PRNewswire-FirstCall/ -- Immucor, Inc., (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today it is responding to an FDA warning letter posted today on the FDA website (http://www.fda.gov/foi/warning.htm).

Immucor CEO Dr. Gioacchino De Chirico said: "Our industry is highly regulated by the FDA, and we are subject to periodic inspection as a normal part of our business. We take our regulatory responsibilities very seriously and are working diligently to respond to the FDA as soon as possible. The FDA has not ordered the recall of any of our products, or placed any limitations on the manufacture or distribution of any of our products."

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.

For more information on Immucor, please visit our website at http://www.immucor.com .

Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning Immucor's expectations, beliefs, intentions or strategies for the future. Forward-looking statements may be identified by words such as "plans," "expects," "believes," "anticipates," "estimates," "projects," "may," "will," "could", "should" and other words of similar meaning. Investors are cautioned not to place undue reliance on any forward-looking statements, and Immucor assumes no obligation to update any forward-looking statements. Immucor urges investors to consider the risks detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Immucor Announces Record Fiscal Third Quarter Results
2. Immucor Schedules Third Quarter Earnings Release and Conference Call
3. Immucor, Inc. Adds Director to Board
4. Immucor Announces Update to Second Quarter Conference Call Number
5. Immucor, Inc. Appoints New Chief Financial Officer
6. Immucor Announces Record Fiscal First Quarter Revenues
7. Immucor Schedules First Quarter Earnings Release and Conference Call
8. Statement of SEIU Spokesperson Andrew McDonald Responding to Announcement of Lawsuit by SEIU UHW-W
9. Home Care Agencies Responding to Patients Needs - Still Have Room for Improvement
10. Warning: New Skin Cancer Study Finds Outdoor Workers are Less Likely to Get Screened for Skin Cancer
11. Some women more likely to miss or ignore heart attack warning signs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega ... Omega Station” is the creation of published author, Chris Jackson. Chris Jackson grew ... works in the Dallas Independent School District teaching English. He is heavily involved in ...
(Date:4/24/2017)... ... ... A 2-in-1 bottleless water appliance provides both purified drinking ... here are the ways in which this technology can benefit dental offices: , ... oxygenated water, with both cold and hot options. , Convenience for Dentists and ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... shows that U.S. consumers can save an average of 70% when buying medication ... (up to 97%) are available when purchasing from other countries. The report (chart ...
(Date:4/21/2017)... West Palm Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at ... FACS , will be taking part in the 2017 London Marathon. Set to take place ... variety of charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: